Anyone looking to learn how a quant fund conquered the financial world should go out and buy Greg Zuckerman’s “The Man Who Solved the Market” when it’s released next week...
Keep Reading →
November 1 - Hedge Funds, Insider Trading - Comments
Baker Bros. Advisors purchased about 1.2 million shares of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) for about $19 per share last week.
Keep Reading →
September 24 - Hedge Funds, Insider Trading, News - Comments
Biotechnology is a very interesting industry to invest in, but also very complex.
Keep Reading →
May 1 - Hedge Funds, News - Comments
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
Keep Reading →
March 15 - Hedge Funds - Comments
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
Keep Reading →
March 12 - Hedge Funds - Comments
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
Keep Reading →
February 7 - Hedge Funds - Comments
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
Keep Reading →
January 26 - Hedge Funds - Comments
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
Keep Reading →
November 21 - Hedge Funds - Comments
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
Keep Reading →
November 20 - Hedge Funds - Comments
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
Keep Reading →
October 31 - Hedge Funds - Comments
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
Keep Reading →
October 17 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
August 15 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
August 3 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
June 2 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
May 18 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
May 18 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
April 15 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
March 30 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
March 30 - Hedge Funds - Comments
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years.
Keep Reading →
November 24 - Hedge Fund Analysis, Hedge Funds, News - Comments
A newly-amended 13D filing with the Securities and Exchange Commission revealed that Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) has signed an Underwriting Agreement with Leerink...
Keep Reading →
September 22 - Hedge Funds, News - Comments
Julian and Felix Baker's Baker Bros.
Keep Reading →
September 16 - Hedge Funds, News - Comments
Julian Baker and Felix Baker's Baker Bros.
Keep Reading →
August 17 - Hedge Funds, News - Comments
Julian Baker and Felix Baker, the managers of Baker Bros.
Keep Reading →
August 15 - Hedge Funds, News - Comments
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors.
Keep Reading →
March 8 - Hedge Funds, News - Comments
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
Keep Reading →
February 25 - Hedge Funds, News - Comments
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker's Baker Bros.
Keep Reading →
February 24 - Hedge Funds, News - Comments
Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should have avoided to invest in...
Keep Reading →
February 24 - Hedge Funds, News - Comments
As a new 13D filing with the SEC has revealed, Julian and Felix Bakers' Baker Bros.
Keep Reading →
February 22 - Hedge Funds, News - Comments
According to a recent filing with the Securities and Exchange Commission, Julian and Felix Bakers' Baker Bros.
Keep Reading →
February 10 - Hedge Funds, News - Comments
According to statistics from Hedge Fund Research, the average hedge fund lost 2.76% in January, compared to a decline of approximately 5% for the S&P 500 benchmark, so hedge ...
Keep Reading →
February 10 - Hedge Funds, News - Comments
Most equity investments made by hedge funds are based on strong reasoning and comprehensive analysis, so these investment vehicles do not make blind bets without laying out ...
Keep Reading →
January 29 - Hedge Funds, News - Comments
There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking the moves of elite hedge...
Keep Reading →
January 28 - Hedge Funds, News - Comments
The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990.
Keep Reading →
January 22 - Commodities, Hedge Funds, News - Comments
At Insider Monkey, we closely monitor the moves made by activist investors.
Keep Reading →
January 20 - Hedge Funds - Comments
According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared with 291 recorded a year...
Keep Reading →
December 28 - Hedge Funds, News - Comments
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today.
Keep Reading →
December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman.
Keep Reading →
November 23 - Hedge Fund Analysis, Hedge Funds, News - Comments
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN).
Keep Reading →
September 16 - Hedge Funds, News - Comments
At Insider Monkey, we track over 700 hedge funds and investment companies, which allows us to understand the market sentiment towards any given stock. Baker Bros.
Keep Reading →
August 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) soared to a lofty $140.00 per share pre-market high today, or a whopping 65.47% higher than the stock’s closing price of $...
Keep Reading →
July 13 - Hedge Funds, News - Comments
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker's Baker Bros. Advisors is making a habit of hitting home runs in 2015.
Keep Reading →
July 10 - Hedge Funds, News - Comments
Julian Baker and Felix Baker's Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015.
Keep Reading →
March 5 - Hedge Funds, News - Comments
Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics, Inc. (NASDAQ:MRTX).
Keep Reading →
February 4 - Hedge Funds, News - Comments
Another one of the funds we track here at Insider Monkey has made a big move into Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), as it was revealed in a filing that Richard...
Keep Reading →
January 26 - Hedge Funds, News - Comments
It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position in Tekmira Pharmaceuticals...
Keep Reading →
January 21 - Hedge Funds, News - Comments
As a new filing with the Securities and Exchange Commission showed, Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) has been added to the equity portfolio of Julian and Felix Bakers...
Keep Reading →
January 13 - Hedge Funds, News - Comments
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday.
Keep Reading →
December 29 - Hedge Funds, News - Comments
